MedPath

Efficacy of an attachment-based working alliance in multimodal pain treatment - Amendment

Not Applicable
Conditions
F45.40
F45.41
Registration Number
DRKS00013323
Lead Sponsor
Schmerztherapie Tagesklinik Orthopädie Heidelberg
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
208
Inclusion Criteria

Our participants are enrolled as outpatients in the orthopedic clinic of the Heidelberg University Hospital and participate in a four-week multidisciplinary pain treatment including physiotherapy, ergotherapy, music and dance therapy, individual and group psychotherapy. As such, they
- have experienced chronic pain for at least six months
- are between 18 and 80 years of age
- have previously received standard treatment consisting of at least one rehabilitation program or two inpatient treatments or one pain treatment with a registered doctor, which did not yield lasting effects.

The participants of control group are
- between 18 - 65 years old
- understand the study and can answer the questions of the questionnaire independently
- written, signed consent

Exclusion Criteria

- high CRP levels as an indicator of rheumatoid arthritis
- acute inflammations of the spine
- a tumor
- a diagnosed psychosis
- a diagnosis of a bipolar or neurological disorder
- an insufficient ability to communicate in German

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
With two Visual Analogue Scales, we assess the pain intensity at present and within the previous week. We also look at the Oxytocin-levels as well as Vasopressin levels at each measurement point. Physical functioning will be assessed with the Oswestry Disability Index by Mannion et al. (2006). Also, we included a widely used German short version of the Health Survey to assess physical functioning and health-related quality of life more generally (Bullinger and Kirchberger, 1998). All of those questionnaires were assessed at T1 (beginning of Treatment), T2 (middle of treatment), T3 (after Treatment) and T4 (3 months after Treatment).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath